GLP1R and diabetes mellitus: Similar patterns follow for GLP-1anlogs with varying restrictions since the first GLP-1 agonist, liraglutide, was added to formulary in 2010 [17, 18] More recently, semaglutide pills were approved in 2020 but only Ontario has it listed in their formulary as a diabetes medication, while the other provinces and territories do not [17, 18].